Platelet-derived endothelial cell growth factor/thymidine phosphorylase immunohistochemical expression in lymphoid tissue and lymphoid malignancies

Human Pathology

Volumn 28, Issue 10, 1997, Pages 1146-1151

  Doussis Anagnostopoulou, Ipatia A ^a   Remadi, Sami ^b   Turley, Helen ^b   Gindre, Patrizia ^b   Comley, Margaret ^b   Borisch, Bettina ^b   Gatter, Kevin C ^b  

^a UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^b NONE

Author keywords

Immunohistochemistry; Lymphoid tissue; Malignant lymphomas; Platelet derived endothelial cell growth factor; Thymidine phosphorylase

Indexed keywords

PLATELET DERIVED ENDOTHELIAL CELL GROWTH FACTOR; THYMIDINE PHOSPHORYLASE;

ARTICLE; CELL PROLIFERATION; ENDOTHELIUM CELL; GLYCOSYLATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LYMPHOCYTE PROLIFERATION; LYMPHOID TISSUE; LYMPHOMA; NUCLEIC ACID METABOLISM; RECEPTOR UPREGULATION; RETICULUM CELL; TISSUE DISTRIBUTION;

EID: 0030773918     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0046-8177(97)90252-5     Document Type: Article

References (30)

1. Friedkin M, Roberts D: The enzymatic synthesis of nucleosides. II. Thymidine and related pyrimidine nucleosides. J Biol Chem 207:257-266, 1954
2. Yoshimura A, Kuwazuru Y, Furukawa T, et al: Purification and tissue distribution of human thymidine phosphorylase; High expression in lymphocytes, reticulocytes and tumors. Biochim Biophys Acta 1034:107-113, 1990
3. Zimmerman M, Seidenberg J: Thymidine phosphorylase and nucleoside deoxyribosyltransferase in normal and malignant tissues. J Biol Chem 230:2618-2621, 1964
4. Touffet S, Gayet G, Samperez S, et al: Mise en evidence d'une activite thymidine phosphorylase dans la prostate saine, adenomateuse et cancereuse. Bull Cancer Paris 79:151-159, 1992
5. Miyazono K, Okabe T, Urabe A, et al: Purification and properties of an endothelial cell growth factor from human platelets. J Biol Chem 262:4098-4103, 1987
6. Ishikawa F, Miyazono K, Hellman U, et al: Identification of angiogenic activity and the cloning and expression of platelet derived endothelial cell growth factor. Nature 338:557-562, 1989
7. Usuku K, Saras J, Waltenberger J, et al: Platelet derived endothelial cell growth factor has thymidine phosphorylase activity. Biochem Biophys Res Commun 184:1311-1316, 1992
8. Furukawa T, Yoshimura A, Sumizawa T, et al. Angiogenic factor. Nature 356:668, 1992
9. Moghaddam A, Bicknell R: Expression of platelet derived endothelial cell growth factor in Escherichia coli and confirmation of its thymidine phosphorylase activity. Biochemistry 31:12141-12146, 1992
10. Finnis C, Dodsworth N, Pollitt CE, et al: Thymidine phosphorylase activity of platelet derived endothelial cell growth factor is responsible for endothelial cell mitogenicity. Eur J Biochem 212:201-210, 1993
11. Fox SB, Moghaddam A, Westwood M, et al: Platelet derived endothelial cell growth factor/thymidine phosphorylase expression in normal tissues: An immunohistochemical study. J Pathol 176:183-190, 1995
12. Pauly JL, Schuller MG, Zelcer AA, et al: Identification and comparative analysis of thymidine phosphorylase in the plasma of healthy subjects and cancer patients. J Natl Cancer Inst 58:1587-1590, 1977
13. Pauly JL, Paolini NS, Ebarb RL, et al: Elevated thymidine phosphorylase activity in the plasma and ascitic fluids of tumour-bearing animals. Proc Soc Exp Biol Med 157:262-267, 1978
14. Heldin N-H, Usuki K, Bergh J, et al: Differential expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase in human lung carcinoma cell lines. Br J Cancer 68:708-711, 1993
15. Reynolds K, Farzaneh F, Collins WP, et al: Association of ovarian malignancy with expression of platelet derived endothelial cell growth factor. J Natl Cancer Inst 86:1234-1238, 1994
16. Toi M, Hoshina S, Taniguchi T, et al: Expression of platelet derived endothelial cell growth factor/thymidine phosphorylase in human best cancer. Int J Cancer 64:79-82, 1995
17. Fox SB, Westwood M, Whitehouse RM, et al: The angiogenic factor platelet derived endothelial cell growth factor/thymidine phos-phorylase is upregulated in breast cancer epithelium and endothelium. Br J Cancer 73:275-280, 1996
18. Shiotani T, Hashimoto Y, Tanaka T, et al: Behavior of activities of thymidine metabolizing enzymes in human Leukemia-Lymphoma cells. Cancer Res 49:1090-1094, 1989
19. Maeda K, Chung Y-S, Ogawa Y, et al: Thymidine phosphorylase/platelet-derived endothelial cell growth factor expression associated with hepatic metastasis in gastric carcinoma. Br J Cancer 73:884-888, 1996
20. Scoazec JY, Berger F, Magaud JP, et al: The dendritic reticulum cell pattern in B cell lymphomas of the small cleaved, mixed and large cell types: An immunohistochemical study of 48 cases. Human Pathol 20:124-131, 1989
21. Alavaikko MJ, Hansmann ML, Nebendahl C, et al: Follicular dendritic cells in Hodgkin's disease. Am J Clin Pathol 95:194-200, 1991
22. Alavaikko MJ, Blanco G, Aine R, et al: Follicular dendritic cells have prognostic relevance in Hodgkin's disease. Am J Clin Pathol 101:761-767, 1994
23. Hsu S-M, Waldron JW, Hsu P-L, et al: Cytokines in malignant lymphomas: Review and prospective evaluation. HUMAN PATHOL 24:1040-1057, 1993
24. Schwaller J, Tobler A, Niklaus G, et al: Interleukm-12 expression in human lymphomas and nonneoplastic lymphoid disorders. Blood 85:2182-2188, 1995
25. Macon WR, Cousar JB, Waldron JA, et al: Interleukin-4 may contribute to the abundant T-cell reaction and paucity of neoplastic B-cells in T-cell rich B-cell lymphomas. Am J Pathol 141:1031-1036, 1992
26. Foss H-D, Herbst H, Gottstein S, et al: Interleukin-8 in Hodgkin's disease: Preferential expression by reactive cells and association with neutrophil density. Am J Pathol 148:1229-1236, 1996
27. Eda H, Fujimoto K, Watanabe S, et al: Cytokines induce thymidine phosphorylase expression in tumour cells and make them more susceptible to 5-deoxy-5-fluorouridine. Cancer Chemother Pharmacol 32:333-338, 1993
28. Schwartz EL, Baptiste N, Walder S, et al: Thymidine phosphorylase mediates the sensitivity of human colon carcinoma cells to 5-fluorouracil. J Biol Chem 270:19073-19077, 1995
29. Schwartz EL, Baptiste N, Megati S, et al: 5-Ethoxy-2-deoxyuridine, a novel substrate for thymidine phosphorylase, potentiates the antitumor activity of 5-fluorouracil when used in combinasion with interferon, an inducer of thymidine phosphorylase expression. Cancer Res 55:3543-3550, 1995
30. Patterson AV, Zhang H, Moghaddam A, et al: Increased sensitivity to the prodrug 5-deoxy-5-fluorouridine and modulation of 5-fluoro-2-deoxyuridine sensitivity in MCF-7 cells transfected with thymidine phosphorylase. Br J Cancer 72:669-675, 1995